Yuqi Luo

1.4k citations
59 papers · 1.1k indexed · 1 hit paper · h-index 18

Impact in

Papers in

Yuqi Luo

52 papers receiving 1.0k citations

Hit Papers

The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options 2021 · 195 citations
195202120262022202450100150

Peers

Yuqi Luo
Comparison fields: 5 of 106
  • Biological Psychiatry 45
  • Neurology 157
  • Cancer Research 149
  • Neurology 68
  • Nephrology 54
Replace Ling Long with:
Ling Long China
Chun Wang China
Xiaojing Li China
Xiang Wang China
Liu‐Lin Xiong China
Na Wei China
Seil Sohn South Korea
Zheng Liu China
Xiaoyu Cheng China
Xiuhua Wu China
Yuqi Luo relative to Ling Long China Ling Long's profile →
Citations per field
00.5×1.5×
Ling Long · 1×
Citations per year

Countries citing papers authored by Yuqi Luo

Since Specialization
Citations

This map shows the geographic impact of Yuqi Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuqi Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuqi Luo more than expected).

Fields of papers citing papers by Yuqi Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuqi Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuqi Luo. The network helps show where Yuqi Luo may publish in the future.

Co-authors

The 25 scholars most cited alongside Yuqi Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yuqi Luo Line = papers co-authored together Yuqi Luo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202517
2 20250
3 20250
4 20251
5 20250
6 20257
7 202428
8 20243
9 20232
10 20239
11 20237
12 202342
13 20234
14 20228
15 202170
16 201519
17 20141
18 201437
19 201429
20 201433

About Yuqi Luo

Yuqi Luo is a scholar working on Neurology, Neurology, Endocrinology, Diabetes and Metabolism, Cancer Research and Biomaterials, having authored 59 papers that have together received 1.1k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (9 papers), Graphene and Nanomaterials Applications (8 papers), Carbon and Quantum Dots Applications (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers), Peroxisome Proliferator-Activated Receptors (4 papers), Cancer-related molecular mechanisms research (4 papers) and Fibroblast Growth Factor Research (3 papers). The work is most often cited by research in Biological Psychiatry (45 citations), Neurology (157 citations), Cancer Research (149 citations), Neurology (68 citations) and Nephrology (54 citations). Yuqi Luo has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Qing Wang, Weiping Jia, Yuqian Bao, Sven Pettersson, Richard Reynolds, К. Ray Chaudhuri, Eng‐King Tan, Xiaojing Ma, Yaping Hao and Yunfeng Xiao. Their work appears in journals such as Scientific Reports, Aging and Disease, PLoS ONE, Acta Pharmacologica Sinica and Frontiers in Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026